These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 14931988)
21. [Treatment of a case of poisoning with stovarsol with BAL]. POPOVIC S Med Arh; 1952; 6(1):55-62. PubMed ID: 14947473 [No Abstract] [Full Text] [Related]
22. [Dithioglycerine (BAL) from the DDR]. KLUMBIES G Dtsch Gesundheitsw; 1952 Aug; 7(35):1096-8. PubMed ID: 13020467 [No Abstract] [Full Text] [Related]
23. [First applications of BAL in Montevideo in the treatment of arsenic and mercury poisoning]. MARTINEZ PRADO G; COMEZ DEL VALLE C Arch Urug Med Cir Espec; 1950 Dec; 37(6):493-505. PubMed ID: 14895374 [No Abstract] [Full Text] [Related]
24. BAL therapy in chronic lead poisoning. GIANNATTASIO RC; PIROZZI MJ; BEDO AV; JENNINGS KG Pediatrics; 1952 Nov; 10(5):603-11. PubMed ID: 13003406 [No Abstract] [Full Text] [Related]
25. ACTH treatment of gold and arsphenamine dermatitis. REYMANN F; SØBYE P; GILG E; SCHWARTZ M; BRODTHAGEN H Acta Derm Venereol; 1952; 32(2):131-5. PubMed ID: 14923189 [No Abstract] [Full Text] [Related]
26. [BAL therapy of chronic arsenic poisoning from drinking water]. ZINNY M; BERLANGA R; MENDIZABAL J Prensa Med Argent; 1951 Sep; 38(37):2378-80. PubMed ID: 14883106 [No Abstract] [Full Text] [Related]
27. BAL therapy in lead poisoning. GIANNATTASIO RC N Y State J Med; 1956 Nov; 56(22):3510-1. PubMed ID: 13369801 [No Abstract] [Full Text] [Related]
28. [Current status of BAL therapy]. PESSAGNO ESPORA MA Dia Med; 1955 Aug; 27(61):1962-7. PubMed ID: 13261851 [No Abstract] [Full Text] [Related]
29. [Action of dimercaprol (BAL) on the experimental poisoning of the cynocephale monkey (Papio papio) with dibutyl lead diacetate (DPD). Comparison with toxicity to rats]. Gras G; Giono H C R Seances Soc Biol Fil; 1971; 165(7):1796-800. PubMed ID: 4261950 [No Abstract] [Full Text] [Related]
30. [Two cases of encephalopathy caused by tetraethyl lead poisoning; treatment with BAL]. KEPSKI A; SŁOMSKI P Neurol Neurochir Psychiatr Pol; 1955; 5(1):89-100. PubMed ID: 14383928 [No Abstract] [Full Text] [Related]
31. [Transplantation of bone marrow in the treatment of thrombopenic purpura due to bismuth-arsenobenzol]. COLARUSSO A Prog Med (Napoli); 1951 Sep; 7(17):513-6. PubMed ID: 14900239 [No Abstract] [Full Text] [Related]
33. [The evaluation of liver damage in arsenobenzol therapy and its elimination]. LAZAROVITS L; KAROLYI I Borgyogy Venerol Sz; 1953 Mar; 7(2):43-4. PubMed ID: 13066522 [No Abstract] [Full Text] [Related]
34. The effects of BAL on the metabolism of lead and on the symptomatology in lead intoxication. VIGLIANI EC; ZURLO N Br J Ind Med; 1951 Oct; 8(4):218-25. PubMed ID: 14878956 [No Abstract] [Full Text] [Related]
35. [Therapy of sublimate poisoning]. SAEXINGER H Wien Med Wochenschr; 1952 Sep; 102(39):786-9. PubMed ID: 13006322 [No Abstract] [Full Text] [Related]
36. [Chalcosis of the crystalline lens: effect of BAL]. ROUHER F Bull Soc Ophtalmol Fr; 1958 Jan; 1():19-20. PubMed ID: 13546934 [No Abstract] [Full Text] [Related]
37. Use of BAL in the treatment of arsenical neuropathy. MALHOTRA SL Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288 [No Abstract] [Full Text] [Related]
38. [Studies on jaundice due to arsenobenzol]. GRANA A Rass Dermatol Sifilogr; 1952; 5(5):279-86. PubMed ID: 13064418 [No Abstract] [Full Text] [Related]
39. The use of bal in the treatment of acute lead encephalopathy. DEANE GE; HELDRICH FJ; BRADLEY JE J Pediatr; 1953 Apr; 42(4):409-13. PubMed ID: 13053327 [No Abstract] [Full Text] [Related]
40. [Arsenical encephalopathy; clinical case cured with BAL, similar case without treatment with fatal outcome]. MONTERO R; BEATO J Rev Chil Pediatr; 1952 May; 23(5):179-84. PubMed ID: 14949536 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]